BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9335554)

  • 1. Mechanism of action of the unusually potent microtubule inhibitor cryptophycin 1.
    Panda D; Himes RH; Moore RE; Wilson L; Jordan MA
    Biochemistry; 1997 Oct; 36(42):12948-53. PubMed ID: 9335554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action.
    Jordan MA; Walker D; de Arruda M; Barlozzari T; Panda D
    Biochemistry; 1998 Dec; 37(50):17571-8. PubMed ID: 9860873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative mechanism of action of cryptophycin-52: kinetic stabilization of microtubule dynamics by high-affinity binding to microtubule ends.
    Panda D; DeLuca K; Williams D; Jordan MA; Wilson L
    Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9313-8. PubMed ID: 9689077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism.
    Derry WB; Wilson L; Jordan MA
    Cancer Res; 1998 Mar; 58(6):1177-84. PubMed ID: 9515803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action cryptophycin. Interaction with the Vinca alkaloid domain of tubulin.
    Smith CD; Zhang X
    J Biol Chem; 1996 Mar; 271(11):6192-8. PubMed ID: 8626409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptophycin: a new antimicrotubule agent active against drug-resistant cells.
    Smith CD; Zhang X; Mooberry SL; Patterson GM; Moore RE
    Cancer Res; 1994 Jul; 54(14):3779-84. PubMed ID: 7913408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of cryptophycin 1 with tubulin and microtubules.
    Kerksiek K; Mejillano MR; Schwartz RE; Georg GI; Himes RH
    FEBS Lett; 1995 Dec; 377(1):59-61. PubMed ID: 8543019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
    Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
    Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes.
    Derry WB; Wilson L; Khan IA; Luduena RF; Jordan MA
    Biochemistry; 1997 Mar; 36(12):3554-62. PubMed ID: 9132006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dicoumarol: a unique microtubule stabilizing natural product that is synergistic with Taxol.
    Madari H; Panda D; Wilson L; Jacobs RS
    Cancer Res; 2003 Mar; 63(6):1214-20. PubMed ID: 12649179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of antimitotic peptides and depsipeptides with tubulin.
    Hamel E
    Biopolymers; 2002; 66(3):142-60. PubMed ID: 12385035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
    Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
    Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of the antimitotic peptide and depsipeptide binding site on beta-tubulin.
    Mitra A; Sept D
    Biochemistry; 2004 Nov; 43(44):13955-62. PubMed ID: 15518544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estramustine depolymerizes microtubules by binding to tubulin.
    Dahllöf B; Billström A; Cabral F; Hartley-Asp B
    Cancer Res; 1993 Oct; 53(19):4573-81. PubMed ID: 8402630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo.
    Loganzo F; Discafani CM; Annable T; Beyer C; Musto S; Hari M; Tan X; Hardy C; Hernandez R; Baxter M; Singanallore T; Khafizova G; Poruchynsky MS; Fojo T; Nieman JA; Ayral-Kaloustian S; Zask A; Andersen RJ; Greenberger LM
    Cancer Res; 2003 Apr; 63(8):1838-45. PubMed ID: 12702571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines.
    Wagner MM; Paul DC; Shih C; Jordan MA; Wilson L; Williams DC
    Cancer Chemother Pharmacol; 1999; 43(2):115-25. PubMed ID: 9923816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stathmin family protein SCG10 differentially regulates the plus and minus end dynamics of microtubules at steady state in vitro: implications for its role in neurite outgrowth.
    Manna T; Grenningloh G; Miller HP; Wilson L
    Biochemistry; 2007 Mar; 46(11):3543-52. PubMed ID: 17311410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.
    ter Haar E; Kowalski RJ; Hamel E; Lin CM; Longley RE; Gunasekera SP; Rosenkranz HS; Day BW
    Biochemistry; 1996 Jan; 35(1):243-50. PubMed ID: 8555181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-alpha production with antitumor activity.
    Zhang LH; Wu L; Raymon HK; Chen RS; Corral L; Shirley MA; Narla RK; Gamez J; Muller GW; Stirling DI; Bartlett JB; Schafer PH; Payvandi F
    Cancer Res; 2006 Jan; 66(2):951-9. PubMed ID: 16424030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halohydrin analogues of cryptophycin 1: synthesis and biological activity.
    Georg GI; Ali SM; Stella VJ; Waugh WN; Himes RH
    Bioorg Med Chem Lett; 1998 Aug; 8(15):1959-62. PubMed ID: 9873466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.